Autophagy activator AA-20 improves proteostasis and extends Caenorhabditis elegans lifespan

The degradation of cellular components through autophagy(definition) is essential for longevity and healthy aging. However, autophagy function decreases with aging, contributing to age-related diseases. In this study, we characterized a small-molecule activator of autophagy called AA-20 that enhances autophagy and lipid droplet clearance in human cells and in the nematode Caenorhabditis elegans . AA-20 reduces polyglutamine aggregation in an autophagy-dependent manner in both human cells and C. elegans , where it also promotes fitness. Consistently, we found that AA-20 extends lifespan in WT C. elegans, but not in autophagy-deficient mutants. Interestingly, our findings suggest that AA-20 acts, at least in part, through a mechanism involving the transcription factor EB, but without inhibiting the protein kinase mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) complex 1. Collectively, our results identify an autophagy activator AA-20 , which may have potential therapeutic implications for aging-related proteinopathies and lipid storage disorders.